The Xa factor: not looking so promising for Pfizer and Bristol - Bristol-Myers Squibb and Pfizer's apixaban blood clot preventer raised rates of bleeding in a 6-month study but showed some encouraging …
Pharma News 5_16
There's a ton of stuff going on this week, plus we're in pre-ASCO mode (so lots of oncology news - scroll down for those headlines). Here we go: What's a vaptan? Maybe something pretty exciting - A …
Pharma News 2_23
Novartis Pharma US CEO Alex Gorsky resigns. Genentech's Avastin and breast cancer - meets study goals, gets approved. Heparin investigation gets ugly for Baxter. If you click on the link in the 2nd …